American Diabetes Association guidelines recommend that combination therapy be started in patients with unachieved glycemic control within three months.
Read More »Intermittent vs. Continuous Energy Restriction for Weight Loss and Metabolic Improvement
Just one lifestyle modification can go a long way.
Read More »Using Electromagnetic Fields to Treat Diabetes
Researchers say static electromagnetic fields (EMFs) could be a non-invasive and safe way of managing blood glucose.
Read More »How Anemia Affects A1c
A new study shows that resolving iron deficiency and or vitamin B12 deficiency anemia may affect A1c levels. One of the most common tools used to screen for and evaluate a person’s control of diabetes is a glycated hemoglobin (A1c) test. An A1c test is advantageous because it reflects a patient’s …
Read More »Is It Possible to Train Low-Carb and Compete High-Carb?
By Sheri Colberg, PhD
In the past, most elite athletes attempted to improve performance through strategies to achieve "high CHO availability," meaning building up adequate pre-exercise glycogen levels and carbohydrate intake during the competition to meet fuel needs, but more recently many have aimed instead for a strategy called "low CHO availability."
Empagliflozin Benefit in Heart Failure, With or Without Diabetes
Studies of empagliflozin and dapagliflozin have shown to reduce cardiovascular risk, indicating a class effect for heart failure patients.
Read More »Diabetes in Your Pet May Increase Your Risk
A recent cohort study offers more insight into whether cat and dog owners and their pets share a risk of acquiring type 2 diabetes.
Read More »Sometimes Long-term Patient/Healthcare Provider Relationship Must Be Severed
I am a primary care provider in a small private office. A long-term patient of mine, 32 years of age, was recently diagnosed with type 1 diabetes. His insurance is now one I do not participate in. Until his recent diagnosis, he visited annually and paid out of pocket. He wanted to stay with me for his care....
Read More »Analysis of Sotagliflozin’s Effect on Cardiorenal Factors for Type 1 Patients
Can use of the sodium-glucose cotransporter 1 and sodium-glucose cotransporter 2 dual inhibitor in patients with type 1 diabetes preserve kidney function?
Read More »Down Syndrome Youth Have a High Prevalence of Dyslipidemia and Prediabetes
Two-thirds of youth with Down syndrome have a BMI percentile at or above 85, but is this a marker for prediabetes and dyslipidemia in this population?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.